EDQM adopts revised procedures for submitting applications
This article was originally published in SRA
Executive Summary
The European Directorate for the Quality of Medicines and Healthcare has adopted a revised procedure that companies will have to follow when submitting applications for certificates of suitability (CEPs), which guarantee that the quality of companies’ pharmaceutical substances comply with the relevant monographs of the European Pharmacopoeia1,2.